BRIO provides a science-based wellness platform to give people a more proactive understanding of their health. We have watched the COVID-19 pandemic turn the world upside down, and we are redirecting our long-standing relationships with labs, suppliers, and employers to help broaden access to proactive COVID-19 screening of people on the frontlines of this crisis.
Our turn-key, FDA-compliant COVID-19 screen, available for purchase by organizations, can be administered with a simple kit that produces results within 1-3 days of arriving at your door.
We are focusing on organizations whose employees are in frequent contact with the public and therefore face an outsized risk of both contracting and asymptomatically spreading the virus.
In our mission to broaden access to COVID-19 screening, we are employing sample collection methods that can be easily administered outside a clinical setting (such as saliva collection via cheek swab). Please note that these formats may have limitations that can have a higher occurrence of false positive or false negative result than may be seen with the nasopharyngeal testing method that is more widely used in a clinical context. The BRIO kit should not be considered a substitute for medical care. Individuals should continue to follow local and federal guidelines around preventing the spread of and exposure to COVID-19.
For up-to-date COVID-19 guidance, visit:
CDC | WHO | Local Resources
We are currently estimating 1 to 3 days. This includes shipping time from the user to the lab, lab processing operations, and physician review of results.
We are estimating a $250 cost per kit ultimately. As demand grows and our costs decrease, we will immediately pass through any savings to decrease the price.
Screening kits and laboratory analysis are provided by CLIA accredited laboratories. They have received emergency FDA authorization to run this screen after proving concordance with control samples from the CDC.
Unfortunately today there is no comparator other than symptoms and no one has tried sampling random people every day until they later develop symptoms (this would be a massive study to try to implement and currently unfeasible due to test kit shortages). All sources of accuracy are based on outside tests, and assessments. BRIO cannot make any provisions or guarantees about the accuracy of these testing outside of what our CLIA labs have provided us, which is the concurrence/validation that is required to achieve FDA Emergency Use Authorization.
The BRIO COVID-19 Screen is not intended to be used by individuals at home. We are partnering with employers for supervised on-site sample collection and CLIA accredited labs for analysis.These partner labs have received FDA Emergency Use Authorization (EUA) for processing COVID-19 screens.